The following speakers have received an honorarium from Novo Nordisk for their input to and facilitation of this educational material:

- Prof. Aleksander Krag, University of Southern Denmark, Odense University Hospital, Denmark

- Dr Arun Sanyal, Virginia Commonwealth University School of Medicine, Richmond, United States of America

1. Rinella ME, et al. Hepatology. 2023;77:1797–1835

2. EASL, EASD, EASO. J Hepatol. 2024; doi: 10.1016/j.jhep.2024.04.031

3. Machado MV. Front Med (Lausanne). 2023;10:1316284

  • To raise awareness of MASLD/MASH as a manifestation of metabolic disease, and the importance of timely diagnosis to prevent disease progression
  • To improve understanding of risk factors and comorbidities for MASLD/MASH, focusing on obesity
  • To discuss optimal management of people with MASLD/MASH, from diagnosis to treatment, and the role of multidisciplinary collaboration

Speakers